We are live on ! Find out more
BAK icon

Braskem

101 hedge funds and large institutions have $563M invested in Braskem in 2017 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 29 increasing their positions, 38 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 12

12% more funds holding

Funds holding: 90101 (+11)

9% more capital invested

Capital invested by funds: $516M → $563M (+$46.6M)

0.54% more ownership

Funds ownership: 4.85%5.39% (+0.54%)

24% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 38

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
101
Holders Change
+11
Holders Change %
+12.22%
% of All Funds
2.29%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
23
Increased
29
Reduced
38
Closed
12
Calls
$6.93M
Puts
Net Calls
+$6.93M
Net Calls Change
+$7.03M

BAK Hedge Fund Activity: Q4 2017 in Review

101 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Braskem (BAK) for Q4 2017, worth a combined $563M — up 9% from $516M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new BAK positions and 12 closed out — a net gain of 11 holders — while 29 added to existing stakes and 38 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $77.2M. The largest seller was Arrowstreet Capital, cutting an estimated $13.2M.

  • 101 institutional investors held Braskem (BAK) as of Q4 2017, up from 90 in Q3 2017.
  • Funds reported $563M of Braskem stock for Q4 2017, up 9% quarter-over-quarter.
  • 23 funds opened new Braskem positions in Q4 2017 and 12 closed out, a net change of +11 holders.
  • The largest Braskem buyer in Q4 2017 was Adage Capital Partners, an estimated $77.2M added.
  • The largest Braskem seller in Q4 2017 was Arrowstreet Capital, an estimated $13.2M sold.

Based on aggregated 13F filings for Q4 2017.